
Confirm
Abbott Similac Total Comfort HMO Stage 2 Growing-up Formula 820g
byAbbottShow more
Some offer cannot be stacked or used together. Please check the discount summary in My Cart page.
This is not available to Return & Refund
Hong Kong
Home Delivery | Click & Collect
$345.00
Low Stock
65 In Stock
Added to Your Shopping Cart
Product Availability by Store Location
Hong Kong
Home Delivery | Click & Collect
820g Item code 249086
- 100% Partially-Hydrolysed Whey Protein: May improve protein digestion and easy to digest
- 98% Lactose Free: Reduces gastrointestinal discomfort
- 0% Palm Olein Oil: Promotes softer stools
- FOS Prebiotics: Stimulates the growth of beneficial bacteria in gastrointestinal tract
Origin
SpainProduct Description
Abbott Similac® Total Comfort™ HMO2 is a 4X specialized formula* for intolerance prevention. It is a superior choice to manage GI intolerance issues¹ ². The unique combination of PHF and dual immune blend may help to reduce allergenicity³ ⁴ and optimize immune response⁵ ⁶.HMO#: 2'FL HMO suppresses secretion of pro-inflammatory cytokines for immune balancing
NTs^: Promotes T cell maturation & balance in immune responses
100% Partially-Hydrolysed Whey Protein: May improve protein digestion and easy to digest
98% Lactose Free: Reduces gastrointestinal discomfort⁷
0% Palm Olein Oil: Promotes softer stools⁸ ⁹
FOS Prebiotics: Stimulates the growth of beneficial bacteria in gastrointestinal tract¹⁰
*Refers to 100% Partially-Hydrolysed Whey Protein formula can help reduce the risk of high-risk babies' cow's milk protein intolerance, 98% Lactose Free formula can help reduce the risk of lactose intolerance, 0% Palm Olein Oil formula can help reduce the risk of dry and hard stools, and the prebiotics can help soften the stools.
# HMO (Human Milk Oligosaccharide) 2’-FL (2’fucosyllactose) 20mg/100ml, not derived from breastmilk.
^NTs is known as Nucleotides (2.9mg/100ml)
1. Nevo et al, JPGN 45:234-239, 2007.
2. Reverri EJ, et al. 2018.
3. von Berg A, et al. J Allergy Clin Immunol 2008;121:1442-1447.
4. von Berg A, et al. Allergol Select 2017;1:28-38.
5. Buck RH, et al. Pediatr Res 2004 7.
6. Goehring K, et al. J Nutr 2016 8.
7. Lasekan JB, et al. Clin Pediatr (Phila) 2011;50:330–337.
8. Lloyd B, et al. Pediatrics 1999;103:E7.
9. Borschel MW, et al. Clin Pediatr (Phila) 2014;53:1375–1382.
10. Roberfroid M. J Nutr. 2007 Mar; 137(3 Suppl 2):8305-75.